ARCHIVES

ODAC Rejects Amsacrine NDA, Renews Idarubicin

This article is from The Cancer Letter archive.

Vol. 16 No. 35 | September 14, 1990

Download PDF Visit The Full Archive

Related Articles

Chemopreventive Phase I, Preclinical Studies Concept Approved

May 13, 1983

Resource Offered for DNA Probe Mapping

August 14, 1987

Barnett Kramer Next Director Of NCI Division of Cancer Prevention

July 29, 2011

DeVita Emphasizes NCI Prevention In Statement To Senate Committee

February 15, 1980

NCI Moves Ahead To Find “Less-Hazardous” Cigarette

April 19, 1974

Tobacco Council Grants Total 3,348

July 15, 1988